Beyond The Numbers: 8 Analysts Discuss Treace Medical Concepts Stock
Beyond The Numbers: 8 Analysts Discuss Treace Medical Concepts Stock
數字背後：8位分析師討論Treace醫療概念股
Treace Medical Concepts (NASDAQ:TMCI) has been analyzed by 8 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在過去的三個月中，有8位分析師對Treace Medical Concepts（納斯達克股票代碼：TMCI）進行了分析，揭示了從看漲到看跌的不同視角。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他們最近的評級，簡要介紹了過去30天中不斷變化的情緒，並將其與前幾個月進行了比較。
Analysts have set 12-month price targets for Treace Medical Concepts, revealing an average target of $8.25, a high estimate of $16.00, and a low estimate of $5.50. Observing a downward trend, the current average is 38.62% lower than the prior average price target of $13.44.
分析師爲Treace Medical Concepts設定了12個月的目標股價，顯示平均目標股價爲8.25美元，最高估計爲16.00美元，低估值爲5.50美元。從下降趨勢來看，當前的平均價格比之前的平均目標價13.44美元低38.62％。
Exploring Analyst Ratings: An In-Depth Overview
探索分析師評級：深入概述
A clear picture...
通過對...
登入免費觀看全文
登入/註冊